BURLINGTON, Ontario — Shoppers Drug Mart is inviting the community to a special InsuJet Showcase Pop-Up Event on Wednesday, June 19th at 1450 Headon Road, Burlington, hosted by Fabio De Rango, pharmacist, Certified Diabetes Educator, and one of the country’s leading advocates for diabetes care.
This event, taking place at one of Ontario’s first Pharmacist-led Care Clinics, will spotlight InsuJet, a revolutionary needle-free insulin delivery system that’s transforming how Canadians manage diabetes. Attendees will get a firsthand look at this innovative technology, which offers painless insulin delivery and is compatible with all U-100 insulin types. For a limited time, get a 6-month supply of accessories—a $200 value—free with the purchase of an InsuJet Starter Kit.
The event will feature live InsuJet demonstrations, interactive discussions on the benefits of needle-free insulin therapy, and a chance to connect with others living with diabetes. The event will feature special guests from I Challenge Diabetes, including Olympian and founder Chris Jarvis, who will share insights and inspiration.
Event Details:
📅 Date: Wednesday, June 19, 2025
📍 Location: Shoppers Drug Mart, 1450 Headon Road, Burlington, ON L7M 3Z5
📞 Contact: (905) 331-6502
"This is a unique opportunity to explore the future of diabetes care in a welcoming and supportive environment. Whether you're living with diabetes, supporting a loved one, or just curious about innovative health solutions, you won’t want to miss this community-focused event," said the company.
Shoppers Drug Mart and InsuJet to host Diabetes Pop-Up Event
This event, taking place at one of Ontario’s first Pharmacist-led Care Clinics, will spotlight InsuJet, a revolutionary needle-free insulin delivery system that’s transforming how Canadians manage diabetes.
Related
Walgreens expands micro-fulfillment network with new Pennsylvania facility
The new facility will serve nearly 650 Walgreens stores, including 55 locations in Pennsylvania, by automating the dispensing of prescription medications.
Albertsons ordered to pay $900 million in Washington opioid case
A Washington judge ordered Albertsons to pay $900 million for inadequately investigating suspicious opioid prescriptions. The retailer may appeal.
Walgreens takes flu prevention campaign to New York with Jordyn Woods partnership
Chain puts prevention at center court as flu activity increases earlier this season.
athenahealth expands Sage AI assistant across care workflows
athenahealth is expanding its Sage AI assistant across charts, billing, analytics and support to streamline workflows and reduce administrative work.
Latest
Walgreens expands micro-fulfillment network with new Pennsylvania facility
The new facility will serve nearly 650 Walgreens stores, including 55 locations in Pennsylvania, by automating the dispensing of prescription medications.
Reimagining the retail pharmacy experience for today’s consumers
As frontline healthcare destinations, retail pharmacies are well positioned to offer comprehensive patient care that goes beyond prescriptions.
Albertsons ordered to pay $900 million in Washington opioid case
A Washington judge ordered Albertsons to pay $900 million for inadequately investigating suspicious opioid prescriptions. The retailer may appeal.
Bausch Health study highlights alcohol-associated hepatitis burden
Research presented at The Liver Meeting 2026 found high mortality and rehospitalization rates among patients with severe alcohol-associated hepatitis.